| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | See Remarks
1 company
Dake Benjamin T is a See Remarks at Jade Biosciences, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $345K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2024 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 6,853 | $22.37 | $153,326.84 | -61.2% | -91.2% | -87.8% | |
| Apr 1, 2024 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 3,325 | $31.97 | $106,316.54 | -72.0% | -94.5% | -91.8% | |
| Mar 27, 2024 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 11,068 | $27.97 | $309,518.83 | -89.6% | -94.9% | -91.1% | |
| Mar 25, 2024 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 3,432 | $28.01 | $96,119.34 | -72.7% | -94.4% | -90.7% | |
| Mar 18, 2024 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 35,057 | $25.90 | $908,045.53 | -77.5% | -93.7% | -90.6% | |
| Dec 6, 2023 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 10,283 | $16.11 | $165,628.28 | -88.8% | +40.7% | -84.2% | |
| Nov 27, 2023 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 12,517 | $16.24 | $203,237.28 | -90.7% | +29.7% | -83.2% | |
| Nov 24, 2023 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 14,372 | $15.37 | $220,906.40 | -78.5% | +18.4% | -83.3% | |
| Sep 7, 2023 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 3,961 | $15.06 | $59,637.01 | -60.5% | +15.4% | -86.5% | |
| Aug 7, 2023 | JBIO Jade Biosciences, Inc. | See Remarks | Sale+OE | 10,283 | $15.52 | $159,580.15 | -76.7% | -25.2% | -89.3% |